StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > For anyone new here

<< Previous

Bullboard Posts

Next >>

Comment by Skrit37on Sep 18, 2021 12:56pm

162 Views

Post# 33883271

RE:RE:RE:RE:RE:RE:RE:For anyone new here

RelevantStock wrote:
capebretongirl wrote: We simply cannot absorb any more dillution

CBG, what do you mean by that? Because I am pretty sur there will be dillution at some point down the road, before a year for sure.

The proposed consolidation which got squashed at the AGM, is a foreshadowing of this down the road........Revenues would have to be astronomical to avoid dilution in the future......well see what happens

<< Previous

Bullboard Posts

Next >>

New CEO leads Sonoro Energy's vision to expand in MENA